Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 40 years old
- People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height)
- People whose weight has been stable — changing by no more than 3kg — for at least approximately 2 months
- People who do not have a regularly planned exercise or physical activity routine
- Women must have regular menstrual periods and must not have gone through menopause
Who may not be able to join:
- People with abnormal results on a heart electrical activity test (EKG/ECG)
- People with a history or current evidence of heart disease, diabetes, or other conditions affecting metabolism
- People taking medications known to affect fat (lipid) or blood sugar (glucose) levels
- People who are pregnant or currently breastfeeding
- People who use tobacco products or e-cigarettes
- People who have previously had a bad reaction (hypersensitivity) to insulin, human albumin, or potassium chloride injection
- People with allergies or sensitivities to a certain group of local anaesthetics called amide-type anaesthetics (for example, lidocaine)
- People who have a history of high potassium levels in the blood (hyperkalemia), or who may be at risk of developing it — including those taking certain medications such as cardiac glycosides or potassium-sparing diuretics
- People taking blood-thinning (anti-coagulant) medications (such as Coumadin or Rivaroxaban), or people with a known allergy or sensitivity to lidocaine, are not eligible for the biopsy part of this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeffrey Horowitz, PhD, University of Michigan
Phone: 734-647-9850
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin sensitivity; Fatty acid turnover; Adipose tissue capillarization; Adipose tissue fibrosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.